Guangcong Shen
State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine, Tianjin Key Laboratory Of Digestive Cancer
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.
Journal: Cancer biology & medicine
Published: September 30, 2025
Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 02, 2025
HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma.
Journal: Biological procedures online
Published: May 11, 2025
Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 25, 2025
The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer.
Journal: Genomics
Published: March 25, 2025
Adaptation to cystine limitation stress promotes PDAC tumor growth and metastasis through translational upregulation of OxPPP.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2025
Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma.
Journal: Nature communications
Published: November 25, 2024
Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immune infiltration in pancreatic cancer.
Journal: Journal of leukocyte biology
Published: August 09, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026